American Society of Hematology Selects 31 Medical Students and Residents for 2018 HONORS Award
(WASHINGTON, October 2, 2018) – The American Society of Hematology (ASH) announced the names of 17 medical students and 14 residents selected to receive the 2018 Hematology Opportunities for the Next Generation of Research Scientists (HONORS) Award.
The ASH HONORS Award aims to support talented North American medical students and residents who are interested in hematology but have not yet entered a hematology-related training program. Recipients receive a stipend of $5,000 to conduct hematology research projects either in the short-term (up to three months) or flexibly over a longer-term (between three and 12 months) and $1,000 each year for two years to support their attendance at the ASH annual meeting. Each HONORS participant will have an ASH member research mentor who will assist and oversee the awardee’s work and progress.
The 2018 ASH HONORS Award recipients are:
Medical Students:
| Recipients | Research Topics |
| Jihad Aljabban, AB, MMSc Ohio State University Hospital Columbus, OH |
Investigating the role of IFNy and TNFa in driving multiple myeloma pathogenesis |
| Kelsey Busken, MSc University of Missouri Columbia, MO |
A risk stratification model to predict alloimmunization in sickle cell anemia |
| Juan Conde, BS, MS, PhD University of Vermont/Fletcher Allen Health Care Burlington, VT |
Smoking, stroke biomarkers and risk of stroke in a national cohort |
| Vinay Giri, BS Duke University Hospital Durham, NC |
Effects of in-home hematopoietic stem cell transplantation on the gut microbiota |
| Amber Harmon, BS, MPH University of California (Davis) Health System Sacramento, CA |
RDW in clonal hematopoiesis |
| Lauren Hawkins, BS Emory University Atlanta, GA |
A qualitative study of patient and family experience with chronic blood transfusion for sickle cell disease |
| Cameron Hilton, BA Cleveland Clinic Foundation Cleveland, OH |
Improving prediction of myelodysplastic syndrome phenotype using advanced analytics |
| Laura Ibidunni, BS UPMC Medical Education Pittsburgh, PA |
Beliefs and practices among adults with sickle cell disease regarding reproductive health decisions and family planning |
| Taylor Linaburg, BS University of Pennsylvania Philadelphia, PA |
Immune-mediated bone marrow aplasia in patients with Hodgkin lymphoma |
| Hadrian Mendoza, BS Yale-New Haven Medical Center New Haven, CT |
Evaluation of positive T- and B-cell gene rearrangement studies in bone marrow among patients without a definitive diagnosis |
| Kevin Miller, BS College of Medicine, Mayo Clinic Rochester, MN |
Broadening the scope of BCL-2 inhibition in multiple myeloma |
| Bryan Nycz, BA University of Colorado Denver Denver, CO |
Evaluation of microbiome dynamics and infection risk among pediatric patients with acute myelogenous leukemia |
| Marisa Roman, BA Medical College of Wisconsin Affiliated Hospitals Milwaukee, WI |
The association between nervous system sensitization and patient-reported outcomes in patients with sickle cell disease |
| Tolulope Rosanwo, BA Case Western Reserve University - University Hospitals Case Cleveland, OH |
Modeling sickle cell anemia with induced pluripotent stem cells |
| Connor Stewart, BS SUNY Downstate College of Medicine Brooklyn, NY |
Identifying the effects of oncogenic mutations in the nuclear export protein XPO1 in lymphomas |
| Sang Tran, BA University of Maryland Baltimore, MD |
Uncovering the anti-leukemic mechanism of artemisinins through the genetic knockdown of MCL-1 |
| WayAnne Watson, BSM Loma Linda University Medical Center Loma Linda, CA |
Mechanism of biologic therapy to treat high-risk pediatric leukemia |
Residents:
| Recipients | Research Topics |
| Sumedha Arya, MD University of Toronto Toronto, Ontario, Canada |
Are there inequities in access to care amongst women with inherited bleeding disorders? |
| Susanna Awoyode, MBBS, MHS Meharry Medical College Nashville, TN |
Epidemiologic study of premature menopause in women with sickle cell disease |
| Evan Chen, MD, BA Brigham and Women's Hospital/Massachusetts General Hospital Boston, MA |
Clinical features and outcomes of patients with myeloid malignancies harboring splicing factor mutations |
| Sean Clark-Garvey, MD, MPH Thomas Jefferson University Philadelphia, PA |
Mechanisms of drug-induced apoptosis in diffuse large B-cell lymphoma |
| Alexander Coltoff, BA, MD Mount Sinai School of Medicine New York, NY |
Real world outcomes of ruxolitinib for polycythemia vera |
| Mark Faber, DO University at Buffalo Buffalo, NY |
Atherosclerotic vascular disease in myelodysplastic syndrome |
| Amrita Goyal, MD University of Minnesota Minneapolis, MN |
Increased risk of second primary malignancy in patients with mycosis fungoides |
| Yang Jiang, MD University of Texas at Houston/MD Anderson Cancer Center Houston, TX |
Assessing the immune status of patients with chronic myeloid leukemia |
| Vanessa Kennedy, MD Stanford University Stanford, CA |
Evaluation of health burden in adolescent and young adult survivors of acute lymphoblastic leukemia |
| Bindiya Patel, MD Washington University/B-JH/SLCH Consortium St. Louis, MO |
Frailty in multiple myeloma patients: retrospective study of United States veterans |
| Matthew Rees, BA, MD University of Michigan Ann Arbor, MI |
The effect of hemolysis on vaccine response in sickle cell disease |
| Caner Saygin, MD Ohio State University Hospital Columbus, OH |
CBL0137 in acute myeloid leukemia |
| Joy Tang, MD Medical College of Wisconsin Affiliated Hospitals Milwaukee, WI |
Acute myelogenous leukemia interface with the hematopoietic niche |
| James Yoon, MD Emory University Atlanta, GA |
Effect of stem cell boost and donor lymphocyte infusion on the incidence of graft-versus-host disease |
The American Society of Hematology (ASH) (www.hematology.org) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 50 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. ASH publishes Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online. In 2016, ASH launched Blood Advances (www.bloodadvances.org), an online, peer-reviewed open-access journal.
CONTACT:
Sara Khalaf, American Society of Hematology
[email protected]; 202-552-4925
Help ASH Build an Inclusive Hematology Community!
ASH is committed to building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and experiences as it works toward one collective goal: helping hematologists conquer blood diseases worldwide.
How Can You Help?
Visit your My Account page, make needed updates to your demographic details, and select your preferred level of ASH access to your information; aggregated or individually identifiable, or choose not to provide or share your information. By sharing information about who you are, you will help ASH have a better appreciation of the diverse needs and talents present in the field, and help to build a more inclusive, collaborative hematology community. It will take only a few moments to complete!
Update Access to Demographic Information Learn About Our Mission